FDA approval based on data from the global, Phase 3 AGILE trial that demonstrated a statistically significant improvement in event-free survival and overall survival Suzhou, China, 02 Jun, 2022 –The partner of CStone Pharmaceuticals (“CStone”, HKEX: 2616) Servier announced that the U.S. Food...
10.1056/NEJM200003303421303. Article Google Scholar The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. 1979, [http://www.hhs.gov/ohrp/humansubjects/...
NEJM. 2011, 365 (6): 493-505. 10.1056/NEJMoa1105243. Article CAS PubMed PubMed Central Google Scholar Global Networks of People Living with HIV: The Global Criminalisation Scan 2010: Documenting trends, presenting evidence. 2010, GNP, Amsterdam Google Scholar [http://www.gnpplus.net/...
doi:10.1056/NEJMp1405800. Article PubMed Google Scholar Download references Author information Authors and Affiliations VA Health Services Research and Development Service, Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC, 20420, USA Amy M. Kilbourne PhD, MPH & David Atkins ...
(Influenza). If any one of these proves efficacious against COVID-19, a fast-track regulatory approval can be expected96. A good review of this can be found in the British Medical Journal97. The WHO recently launched a mega-trial across multiple countries called SOLIDARITY. The trial will ...
et al. IMpassion130 Trial Investigators. Atezolizumab and Nab-Paclitaxel in advanced triple-negative breast cancer. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1809615. (2018). [Epub ahead of print]. Article PubMed Google Scholar Socinski, M. A., Jotte, R. M., Cappuzzo, F.,...